Common Contracts

PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT by and among Access Pharmaceuticals, Inc. and the parties named herein on Schedule 1, as Purchasers October 25, 2012

Preferred Stock and Warrant Purchase Agreement • October 26th, 2012 • Access Pharmaceuticals Inc • Pharmaceutical preparations • New York

• Contract Type
  Preferred Stock and Warrant Purchase Agreement
• Filed
  October 26th, 2012
• Company
  Access Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is dated as of October 25, 2012, among Access Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers identified on Schedule 1 hereto (each a “Purchaser” and collectively the “Purchasers”).

Preferred Stock and Warrant Purchase Agreement PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT by and among Access Pharmaceuticals, Inc. and the parties named herein on Schedule 1, as Purchasers November 7, 2007

Preferred Stock and Warrant Purchase Agreement • May 22nd, 2008 • Feinberg Larry N • Pharmaceutical preparations • New York

• Contract Type
  Preferred Stock and Warrant Purchase Agreement
• Filed
  May 22nd, 2008
• Company
  Feinberg Larry N
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

AMENDED AND RESTATED PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT by and among Access Pharmaceuticals, Inc. and the parties named herein on Schedule 1, as Purchasers February 4, 2008

Preferred Stock and Warrant Purchase Agreement • March 11th, 2008 • Access Pharmaceuticals Inc • Pharmaceutical preparations • New York

• Contract Type
  Preferred Stock and Warrant Purchase Agreement
• Filed
  March 11th, 2008
• Company
  Access Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This AMENDED AND RESTATED PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is dated as of February 4, 2008, among Access Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers identified on Schedule 1 hereto (each a “Purchaser” and collectively the “Purchasers”).